Bank of America Corp and Citigroup Inc trimmed compensation for their chief executive officers last year, a year in which banks exercised restraint in compensating employees as the pandemic ravaged the economy.
Bank of America reduced CEO Brian Moynihan’s pay by 7.5 percent to US$24.5 million, it said on Friday in a filing. Citigroup curbed compensation for outgoing CEO Michael Corbat by 21 percent to US$19 million, it said.
Both lenders cited the impact of the pandemic in considering the compensation levels.
Bank of America’s board said it evaluated the impact of the virus “on financial performance, its clients, communities and its own employees.”
Citigroup noted the “extraordinary effect” on macroeconomic conditions in the US and globally.
Citi also cited consent orders from the Federal Reserve and the Office of the Comptroller of the Currency for failings of technology infrastructure and internal controls.
The bank has vowed to rectify the problems, with incoming CEO Jane Fraser leading much of the remediation effort.
Citigroup will cut bonuses for dozens of its top executives after the reprimands by regulators, Bloomberg News reported last month.
Corbat was granted stock awards totaling about US$12.3 million, a cash bonus of US$5.3 million and a US$1.5 million salary, the New York-based bank said in its filing.
Moynihan received US$23 million in stock grants and a US$1.5 million salary, the bank said. While he has not been given a cash bonus since 2007, part of his stock award will settle in cash when it vests.
Moynihan is steering the lender through another major economic slump after taking the helm 11 years ago in the wake of the global financial crisis.
Pandemic compensation has sown anger and division among higher-paid employees at the bank, who have pointed to underwhelming payouts and special bonus policies during a bumper year for investment bankers and traders. Meanwhile, lower-paid staff got extra payments of US$750.
The biggest US banks have been frugal on pay as strains on consumer divisions counter a windfall from Wall Street dealmaking and trading.
UNCONVINCING: The US Congress questioned whether the company’s Chinese owners pose a national security risk and how the app might influence young users TikTok chief executive officer Shou Chew (周受資), confronted with an unforgiving, distrustful US Congress, tried to give answers in his testimony on Thursday that avoided offending either the US government or China. However, his evasiveness left Congress unsatisfied, with representatives hungrier than ever to punish TikTok for ties to its parent company ByteDance Ltd (字節跳動), based in Beijing. He did not bring his company any closer to a resolution. Politically, TikTok is in a tougher spot. Its executives had been discussing divesting from ByteDance to resolve US national security concerns, people familiar with the matter told Bloomberg. However, China this week said
Huawei Technologies Co (華為) has replaced more than 13,000 parts in its products that were hit by US trade sanctions, the Chinese tech giant’s founder said, according to a speech transcript from last month posted on Friday by a Chinese university. Ren Zhengfei (任正非) said Huawei had over the past three years replaced the 13,000 components with domestic Chinese substitutes, and had redesigned 4,000 circuit boards for its products, the transcript posted by Shanghai Jiao Tong University said. “As of now, our circuit board [production] has stabilized, because we have a supply of domestically produced components,” Ren said. He did not give details
Sanofi SA’s drug Dupixent succeeded in a late-stage trial for chronic obstructive pulmonary disease (COPD), raising the odds that the blockbuster would be the first biologic medicine cleared to treat the lung disorder. Dupixent, which is already prescribed for asthma and some skin conditions, showed a 30 percent reduction in the rate at which patients’ COPD worsened compared with those who received a placebo during the stage-three Boreas trial, the company said in a statement yesterday. The positive data could herald a new era of cutting-edge treatments for the life-threatening respiratory affliction and provide another major boost in demand for the French
SEMICONDUCTOR EQUIPMENT: The international trade group said the sector would recover from a slump, with spending expected to rise 4.2 percent to US$24.9 billion Taiwan is to retain its position as the top spender on semiconductor front-end equipment and facilities next year, with spending expected to increase 4.2 percent year-on-year to US$24.9 billion, international trade group SEMI said yesterday. The spending forecast matches an expected recovery in global semiconductor equipment and facilities investment next year, it said. International equipment spending is to return to growth next year, SEMI said in a report, forecasting 21 percent growth to US$92 billion. The expansion would manly be driven by robust demand for semiconductors in the automotive and high-performance computing segments, the association said. “This quarter’s SEMI World Fab Forecast update